Please wait while we open this resource.
K
Guidelines & protocols
KDIGO PROVIDED RECOMMENDATIONS ON SGLT2 INHIBITORS AND NONSTEROIDAL MRAS IN PATIENTS WITH DIABETES AND CKD
null
PDF20231 pages44 KB
The KDIGO guidelines have been updated to reflect new data on the benefits of sodium-glucose cotransporter-2 (SGLT2) inhibitors and nonsteroidal mineralocorticoid receptor antagonists (MRAs) in patients with type 2 diabetes and CKD. The update includes one new recommendation for SGLT2 inhibitors for patients with eGFR as low as 20 mL/min/1.73 m² and suggests nonsteroidal MRAs for patients with eGFR ≥25 mL/min/1.73 m² and increased albuminuria. The guidelines emphasize the benefits of early and broad application of these agents in managing patients with type 2 diabetes and proteinuric CKD.
No account needed
Ask this resource
Answers use this document only.
More like this
Resources from the same specialty and type. Curated links will replace these when added.
Clinical Resources
Documents that extend or complement this resource.
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology
Integrated CKD Management Guidelines for Uganda
Same clinical topic · Nephrology
KDIGO 2026 CLINICAL PRACTICE GUIDELINE FOR DIABETES AND CHAPTER 1, CHAPTER 2, & CHAPTER 4 UPDATE DRAFT
Same clinical topic · Nephrology
KDIGO 2025 Clinical Practice Guideline for Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology
KDIGO 2026 Clinical Practice Guideline for the Management of Anemia in Chronic Kidney Disease (CKD)
Same clinical topic · Nephrology
KDIGO-2024-CKD-Guideline
Same clinical topic · Nephrology
DIABETES MANAGEMENT IN CHRONIC KIDNEY DISEASE: SYNOPSIS OF THE KDIGO 2022 CLINICAL PRACTICE GUIDELINE UPDATE
Same clinical topic · Nephrology
KDIGO 2023 CLINICAL PRACTICE GUIDELINE FOR THE MANAGEMENT OF LUPUS NEPHRITIS
Same clinical topic · Nephrology
KDIGO Clinical Practice Guideline for Anemia in Chronic Kidney Disease
Same clinical topic · Nephrology